US EditionDutch-based Hy2Care raises €4.5M from EIC, others for US clinical trial and commecial expansion - Silicon Canals
Summary by Silicon Canals
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Dutch-based Hy2Care raises €4.5M from EIC, others for US clinical trial and commecial expansion - Silicon Canals
Hy2Care, a spin-off company of the MIRA Institute of the University of Twente, has successfully raised €4.5M in new funding to complete critical preparations for its upcoming clinical trial in the United States. Half of the funding comes from the European Innovation Council (EIC) Fund investment awarded to Hy2Care in 2022 as part of the EIC Accelerator. The European Innovation Council Fund from the European Commission is agnostic; it invests acr…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
